XML 55 R42.htm IDEA: XBRL DOCUMENT v3.24.3
Leases - Additional Information (Details)
$ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Feb. 29, 2024
Leases
Jul. 31, 2023
USD ($)
SquareFeet
Mar. 31, 2021
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2023
USD ($)
Mar. 31, 2024
USD ($)
Dec. 31, 2023
USD ($)
Lessee, Lease, Description [Line Items]                  
Lease expiration date Jun. 30, 2026   Jun. 30, 2024     Jun. 30, 2026      
Lease option to extend           The Company exercised its option to extend the lease term through June 30, 2026,      
Lease, existence of option to extend           true      
Lease termination agreement | Leases 2                
Termination, description           The leases contain various termination options      
Operating lease, weighted average remaining lease term       6 years 9 months 18 days   6 years 9 months 18 days      
Operating lease, weighted average discount rate       10.10%   10.10%      
Operating lease costs       $ 600 $ 500 $ 1,800 $ 800    
Variable Lease, Cost       0   200      
Operating lease payments           1,500 $ 600    
Operating lease liabilities       11,036   11,036      
Operating lease right-of-use assets       $ 9,918   $ 9,918     $ 11,509
Minimum                  
Lessee, Lease, Description [Line Items]                  
Lease, remaining term       1 year   1 year      
Maximum                  
Lessee, Lease, Description [Line Items]                  
Lease, remaining term       7 years   7 years      
Laboratory | Belgium                  
Lessee, Lease, Description [Line Items]                  
Lease, term of contract     3 years            
Office Space | Belgium                  
Lessee, Lease, Description [Line Items]                  
Lease, term of contract     3 years            
Neurocrine Biosciences, Inc. | Sublease Agreement                  
Lessee, Lease, Description [Line Items]                  
Operating lease liabilities                 11,000
Operating lease right-of-use assets                 $ 11,000
Neurocrine Biosciences, Inc. | Sublease Agreement | Office Space                  
Lessee, Lease, Description [Line Items]                  
Number of rentable square feet | SquareFeet   35,016              
Sublease term commencing date   Jul. 21, 2023              
Sublease term ending date   Jul. 31, 2031              
Subleasing premises cost   $ 2,000              
Subleasing premises percentage   3.00%              
Subleased premises cost   $ 1,000              
Letter of credit   $ 500              
Security deposit made for letter of credit       $ 500   $ 500      
Encinitas Asset Group                  
Lessee, Lease, Description [Line Items]                  
Operating lease liabilities               $ 900  
Operating lease right-of-use assets               $ 800